Overview of genetics and obsessive-compulsive disorder

Psychiatry Research

Volumn 170, Issue 1, 2009, Pages 7-14

  Nicolini, Humberto ^a,b   Arnold, Paul ^c   Nestadt, Gerald ^d   Lanzagorta, Nuria ^a   Kennedy, James L ^e  

^a Grupo Medico Carracci   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE LA CIUDAD DE MÉXICO   (Mexico)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d JOHNS HOPKINS HOSPITAL   (United States)

^e CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Candidate genes; Endophenotypes; Family studies; Obsessive Compulsive Disorder

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; APOLIPOPROTEIN E; BRAIN DERIVED NEUROTROPHIC FACTOR; CATECHOL METHYLTRANSFERASE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE TRANSPORTER; GLUTAMATE TRANSPORTER; MU OPIATE RECEPTOR; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SEROTONIN 1B RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; VENLAFAXINE;

AGORAPHOBIA; BEHAVIOR GENETICS; BRAIN REGION; CHROMOSOME 3Q; CHROMOSOME 9P; COGNITIVE DEFECT; DISEASE CLASSIFICATION; DRUG RESPONSE; ENVIRONMENTAL FACTOR; FAMILY; GENDER; GENE IDENTIFICATION; GENERALIZED ANXIETY DISORDER; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEREDITY; HERITABILITY; HUMAN; OBSESSIVE COMPULSIVE DISORDER; ONSET AGE; PANIC; PATHOPHYSIOLOGY; PHARMACOGENETICS; PHENOTYPIC VARIATION; PREVALENCE; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TWINS;

ENVIRONMENT; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; OBSESSIVE-COMPULSIVE DISORDER; PEDIGREE; PHENOTYPE; SEX FACTORS;

EID: 70350036040     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2008.10.011     Document Type: Review

References (108)

1. Abramowitz J.S., Schwartz S.A., Moore K.M., and Luenzmann K.R. Obsessive-compulsive symptoms in pregnancy and the puerperium: a review of the literature. Journal of Anxiety Disorders 17 4 (2003) 461-478
2. Alsobrook J., Leckman J., Goodman W., Rasmussen S., and Pauls D. Segregation analysis of obsessive-compulsive disorder using symptom-based factor scores. American Journal of Medical Genetics (Neuropsychiatric Genetics) 88 (1999) 669-675
3. Alsobrook II J.P., Zohar A.H., Leboyer M., Chabane N., Ebstein R.P., and Pauls D.L. Association between the COMT locus and obsessive-compulsive disorder in females but not males. American Journal of Medical Genetics 114 1 (2002) 116-120
4. An S.K., Mataix-Cols D., Lawrence N.S., Wooderson S., Giampietro V., Speckens A., Brammer M.J., and Phillips M.L. To discard or not to discard: the neural basis of hoarding symptoms in obsessive-compulsive disorder. Molecular Psychiatry 14 (2009) 318-331
5. Arnold P.D., Siegel-Bartelt J., Cytrynbaum C., Teshima I., and Schachar R. Velo-cardio-facial syndrome: implications of microdeletion 22q11 for schizophrenia and mood disorders. American Journal of Medical Genetics 105 4 (2001) 354-362
6. Arnold P.D., Summerfeldt L.J., Sicard T., Geronimo J., Trakalo J., Zai G., Hu X., Goldman D., Hanna G., Pato M., Richter M., and Kennedy J. A family-based association study of novel serotonin polymorphisms in OCD and OCD symptom subgroups. American Journal of Medical Genetics (Neuropsychiatric Genetics) 130B (2004) 69
7. Arnold P.D., Sicard T., Burroughs E., Richter M.A., and Kennedy J.L. Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder. Archives of General Psychiatry 63 7 (2006) 769-776
8. Azzam A., and Mathews C.A. Meta-analysis of the association between the catecholamine-O-methyl-transferase gene and obsessive-compulsive disorder. American Journal of Medical Genetics 123B 1 (2003) 64-69
9. Barch D.M. Emotion, motivation, and reward processing in schizophrenia spectrum disorders: what we know and where we need to go. Schizophrenia Bulletin 34 5 (2008) 816-818
10. Bengel D., Greenberg B.D., Cora-Locatelli G., Altemus M., Heils A., Li Q., and Murphy D.L. Association of the serotonin transporter promoter regulatory region polymorphism and obsessive-compulsive disorder. Molecular Psychiatry 4 5 (1999) 463-466
11. Bienvenu O.J., Samuels J.F., Riddle M.A., Hoehn-Saric R., Liang K.Y., Cullen B.A., Grados M.A., and Nestadt G. The relationship of obsessive-compulsive disorder to possible spectrum disorders: results from a family study. Biological Psychiatry 48 4 (2000) 287-293
12. Billett E.A., Richter M.A., King N., Heils A., Lesch K.P., and Kennedy J.L. Obsessive compulsive disorder, response to serotonin reuptake inhibitors and the serotonin transporter gene. Molecular Psychiatry 2 5 (1997) 403-406
13. Billett E.A., Richter M.A., Sam F., Swinson R.P., Dai X.Y., King N., Badri F., Sasaki T., Buchanan J.A., and Kennedy J.L. Investigation of dopamine system genes in obsessive-compulsive disorder. Psychiatric Genetics 8 3 (1998) 163-169
14. Camarena B., Cruz-Fuentes C., De la Fuente J.R., and Nicolini H. A higher frequency of a low activity-related allele of the MAO-A gene in females with obsessive-compulsive disorder. Psychiatric Genetics 8 4 (1998) 255-257
15. Camarena B., Rinetti G., Cruz-Fuentes C., Gomez A., De la Fuente J.R., and Nicolini H. Additional evidence that genetic variation of MAO-A gene supports a gender subtype in obsessive-compulsive disorder. American Journal of Medical Genetics B Neuropsychiatric Genetics 105 3 (2001) 279-282
16. Camarena B., Rinetti G., Cruz-Fuentes C., Hernandez S., de la Fuente J.R., and Nicolini H. Association study of the serotonin transporter gene polymorphism in obsessive-compulsive disorder. International Journal of Neuropsychopharmacology 4 3 (2001) 269-272
17. Camarena B., Aguilar A., Loyzaga C., and Nicolini H. A family-based association study of the 5-HT-1D receptor gene in obsessivecompulsive disorder. International Journal of Neuropsychopharmacology (2004) 49-53
18. Cavallini M.C., Pasquale L., Bellodi L., and Smeraldi E. Complex segregation analysis for obsessive compulsive disorder and related disorders. American Journal of Medical Genetics 88 1 (1999) 38-43
19. Cavallini M.C., Bertelli S., Chiapparino D., Riboldi S., and Bellodi L. Complex segregation analysis of obsessive-compulsive disorder in 141 families of eating disorder probands, with and without obsessive-compulsive disorder. American Journal of Medical Genetics 96 3 (2000) 384-391
20. Cavallini M.C., Di Bella D., Siliprandi F., Malchiodi F., and Bellodi L. Exploratory factor analysis of obsessive-compulsive patients and association with 5-HTTLPR polymorphism. American Journal of Medical Genetics 114 3 (2002) 347-353
21. Chabane N., Delorme R., Millet B., Mouren M.C., Leboyer M., and Pauls D. Early-onset obsessive-compulsive disorder: a subgroup with a specific clinical and familial pattern?. Journal of Child Psychology and Psychiatry 46 8 (2005) 881-887
22. Chamberlain S.R., Fineberg N.A., Menzies L.A., Blackwell A.D., Bullmore E.T., Robbins T.W., and Sahakian B.J. Impaired cognitive flexibility and motor inhibition in unaffected first-degree relatives of patients with obsessive-compulsive disorder. American Journal of Psychiatry 164 2 (2007) 335-338
23. Cruz-Fuentes C., Camarena B., King N., Paez F., Sidenberg D., De la Fuente J.R., and Nicolini H. Increased prevalence of the seven-repeat variant of the dopamine D4 receptor gene in patients with obsessive-compulsive disorder with tics. Neuroscience Letters 231 1 (1997) 1-4
24. Cruz-Fuentes C., Blas C., Gonzalez L., Camarena B., and Nicolini H. Severity of obsessive-compulsive symptoms is related to self-directedness character trait in obsessive-compulsive disorder. CNS Spectrums 9 8 (2004) 607-612
25. Cullen B., Samuels J., Grados M., Landa R., Bienvenu O.J., Liang K.Y., Riddle M., Hoehn-Saric R., and Nestadt G. Social and communication difficulties and obsessive-compulsive disorder. Psychopathology, 41 3 (2008) 194-200
26. Delorme R., Krebs M.O., Chabane N., Roy I., Millet B., Mouren-Simeoni M.C., Maier W., Bourgeron T., and Leboyer M. Frequency and transmission of glutamate receptors GRIK2 and GRIK3 polymorphisms in patients with obsessive compulsive disorder. Neuroreport 15 4 (2004) 699-702
27. Delorme R., Betancur C., Callebert J., Chabane N., Laplanche J.L., Mouren-Simeoni M.C., Launay J.M., and Leboyer M. Platelet serotonergic markers as endophenotypes for obsessive-compulsive disorder. Neuropsychopharmacology 30 8 (2005) 1539-1547
28. de Mathis M.A., do Rosario M.C., Diniz J.B., Torres A.R., Shavitt R.G., Ferrão Y.A., Fossaluza V., de Bragança Pereira C.A., and Miguel E.C. Obsessive-compulsive disorder: influence of age at onset on comorbidity patterns. European Psychiatry. 23 3 (2008) 187-194
29. Denys D., Van Nieuwerburgh F., Deforce D., and Westenberg H.G. Prediction of response to paroxetine and venlafaxine by serotonin-related genes in obsessive-compulsive disorder in a randomized, double-blind trial. Journal of Clinical Psychiatry 68 5 (2007) 747-753 May
30. Di Bella D., Cavallini M.C., and Bellodi L. No association between obsessive-compulsive disorder and the 5-HT1D-beta receptor gene. American Journal of Psychiatry 159 10 (2002) 1783-1785
31. Di Bella D., Erzegovesi S., Cavallini M.C., and Bellodi L. Obsessive-compulsive disorder, 5-HTTLPR polymorphism and treatment response. Pharmacogenomics Journal 2 3 (2002) 176-181
32. Dickel D.E., Veenstra-VanderWeele J., Cox N.J., Wu X., Fischer D.J., Van Etten-Lee M., Himle J.A., Leventhal B.L., Cook Jr. E.H., and Hanna G.L. Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive-compulsive disorder. Archives of General Psychiatry 63 7 (2006) 778-785
33. Do Rosario-Campos M.C., Leckman J.F., Curi M., Quatrano S., Katsovitch L., Miguel E.C., and Pauls D.L. A family study of early-onset obsessive-compulsive disorder. American Journal of Medical Genetics B (Neuropsychiatric Genetics) 136 1 (2005) 92-97
34. Ebstein R.P. The molecular genetic architecture of human personality: beyond self-report questionnaires. Molecular Psychiatry 11 5 (2006) 427-445
35. Frisch A., Michaelovsky E., Rockah R., Amir I., Hermesh H., Laor N., Fuchs C., Zohar J., Lerer B., Buniak S.F., Landa S., Poyurovsky M., Shapira B., and Weizman R. Association between obsessive-compulsive disorder and polymorphisms of genes encoding components of the serotonergic and dopaminergic pathways. European Neuropsychopharmacology 10 3 (2000) 205-209
36. Gothelf D., Presburger G., Zohar A.H., Burg M., Nahmani A., Frydman M., Shohat M., Inbar D., Aviram-Goldring A., Yeshaya J., Steinberg T., Finkelstein Y., Frisch A., Weizman A., and Apter A. Obsessive-compulsive disorder in patients with velocardiofacial (22q11 deletion) syndrome. American Journal of Medical Genetics B (Neuropsychiatric Genetics) 126 1 (2004) 99-105
37. Gottesman I.I., and Gould T. The endophenotype concept in psychiatry; etymology and strategic intentions. American Journal of Psychiatry; 160 3 (2003) 636-645
38. Grabe H.J., Ruhrmann S., Ettelt S., Buhtz F., Hochrein A., Schulze-Rauschenbach S., Meyer K., Kraft S., Reck C., Pukrop R., Freyberger H.J., Klosterkötter J., Falkai P., John U., Maier W., and Wagner M. Familiality of obsessive-compulsive disorder in nonclinical and clinical subjects. American Journal of Psychiatry 163 11 (2006) 1986-1992
39. Grados M.A., Riddle M.A., Samuels J.F., Liang K.Y., Hoehn-Saric R., Bienvenu O.J., Walkup J.T., Song D., and Nestadt G. The familial phenotype of obsessive-compulsive disorder in relation to tic disorders: the Hopkins OCD family study. Biological Psychiatry 50 8 (2001) 559-565 Oct 15
40. Grados M.A., Walkup J., and Walford S. Genetics of obsessive-compulsive disorders: new findings and challenges. Brain Development 25 Suppl 1 (2003) S55-61
41. Graff-Guerrero A., De la Fuente-Sandoval C., Camarena B., Gomez-Martin D., Apiquian R., Fresan A., Aguilar A., Mendez-Nunez J.C., Escalona-Huerta C., Drucker-Colin R., and Nicolini H. Frontal and limbic metabolic differences in subjects selected according to genetic variation of the SLC6A4 gene polymorphism. Neuroimage 25 4 (2005) 1197-1204
42. Hall D., Dhilla A., Charalambous A., Gogos J.A., and Karayiorgou M. Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive-compulsive disorder. American Journal of Human Genetics 73 2 (2003) 370-376
43. Halmi K.A., Tozzi F., Thornton L.M., Crow S., Fichter M.M., Kaplan A.S., Keel P., Klump K.L., Lilenfeld L.R., Mitchell J.E., Plotnicov K.H., Pollice C., Rotondo A., Strober M., Woodside D.B., Berrettini W.H., Kaye W.H., and Bulik C.M. The relation among perfectionism, obsessive-compulsive personality disorder and obsessive-compulsive disorder in individuals with eating disorders. International Journal of Eating Disorders 38 4 (2005) 371-374
44. Hanna G., Veenstra-VanderWeele J., Cox N., Boehnke M., Himle J., Curtis G., Leventhal B., and Cook E. Genome-wide linkage analysis of families with obsessive-compulsive disorder ascertained through pediatric probands. American Journal of Medical Genetics B (Neuropsychiatric Genetics) 114 (2002) 541-552
45. Hanna G.L., Fingerlin T.E., Himle J.A., and Boehnke M. Complex segregation analysis of obsessive-compulsive disorder in families with pediatric probands. Human Heredity 60 1 (2005) 1-9
46. Hanna G.L., Fischer D.J., Chadha K.R., Himle J.A., and Van Etten M. Familial and sporadic subtypes of early-onset obsessive-compulsive disorder. Biological Psychiatry 57 8 (2005) 895-900
47. Hanna G.L., Himle J.A., Curtis G.C., and Gillespie B.W. A family study of obsessive-compulsive disorder with pediatric probands. American Journal of Medical Genetics B Neuropsychiatric Genetics 134 1 (2005) 13-19
48. Hemmings S.M., Kinnear C.J., Niehaus D.J., Moolman-Smook J.C., Lochner C., Knowles J.A., Corfield V.A., and Stein D.J. Investigating the role of dopaminergic and serotonergic candidate genes in obsessive-compulsive disorder. European Neuropsychopharmacology 13 2 (2003) 93-98
49. Hemmings S.M., Kinnear C.J., Lochner C., Niehaus D.J., Knowles J.A., Moolman-Smook J.C., Corfield V.A., and Stein D.J. Early- versus late-onset obsessive-compulsive disorder: investigating genetic and clinical correlates. Psychiatric Research 128 2 (2004) 175-182
50. Hettema J.M., Neale M.C., and Kendler K.S. A review and meta-analysis of the genetic epidemiology of anxiety disorders. American Journal of Psychiatry 158 10 (2001) 1568-1578
51. Hollander E., Kim S., Khanna S., and Pallanti S. Obsessive-compulsive disorder and obsessive-compulsive spectrum disorders: diagnostic and dimensional issues. CNS Spectrums 2 Suppl 3 (2007) 5-13
52. Hudziak J.J., Van Beijsterveldt C.E., Althoff R.R., Stanger C., Rettew D.C., Nelson E.C., Todd R.D., Bartels M., and Boomsma D.I. Genetic and environmental contributions to the Child Behavior Checklist Obsessive-Compulsive Scale: a cross-cultural twin study. Archives of General Psychiatry 61 6 (2004) 608-616
53. Hu X.Z., Lipsky R.H., Zhu G., Akhtar L.A., Taubman J., Greenberg B.D., Xu K., Arnold P.D., Richter M.A., Kennedy J.L., Murphy D.L., and Goldman D. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. American Journal of Human Genetics 78 5 (2006) 815-826
54. Joel D., Zohar O., Afek M., Hermesh H., Lerner L., Kuperman R., Gross-Isseroff R., Weizman A., and Inzelberg R. Impaired procedural learning in obsessive-compulsive disorder and Parkinson's disease, but not in major depressive disorder. Behavior and Brain Research 157 2 (2005) 253-263
55. Jonnal A.H., Gardner C.O., Prescott C.A., and Kendler K.S. Obsessive and compulsive symptoms in a general population sample of female twins. American Journal of Medical Genetics 96 6 (2000) 791-796
56. Karayiorgou M., Altemus M., Galke B.L., Goldman D., Murphy D.L., Ott J., and Gogos J.A. Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder. Proccedings of the National Academy of Sciences 94 9 (1997) 4572-4575
57. Karayiorgou M., Sobin C., Blundell M.L., Galke B.L., Malinova L., Goldberg P., Ott J., and Gogos J.A. Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder. Biological Psychiatry 45 9 (1999) 1178-1189
58. Kuelz A.K., Hohagen F., and Voderholzer U. Neuropsychological performance in obsessive-compulsive disorder: a critical review. Biological Psychology 65 3 (2004) 185-236
59. Leckman J.F., Pauls D.L., Zhang H., Rosario-Campos M.C., Katsovich L., Kidd K.K., Pakstis A.J., Alsobrook J.P., Robertson M.M., McMahon W.M., Walkup J.T., van de Wetering B.J., King R.A., and Cohen D.J. Obsessive-compulsive symptom dimensions in affected sibling pairs diagnosed with Gilles de la Tourette syndrome. American Journal of Medical Genetics B (Neuropsychiatric Genetics) 116 1 (2003) 60-68
60. Levitan R.D., Kaplan A.S., Masellis M., Basile V.S., Richter M.A., and Kennedy J.L. The serotonin-1Dbeta receptor gene and severity of obsessive-compulsive disorder in women with bulimia nervosa. European Neuropsychopharmacology 16 1 (2006) 1-6
61. Lochner C., Hemmings S.M., Kinnear C.J., Moolman-Smook J.C., Corfield V.A., Knowles J.A., Niehaus D.J., and Stein D.J. Gender in obsessive-compulsive disorder: clinical and genetic findings. European Neuropsychopharmacology 14 2 (2004) 105-113
62. Lochner C., Kinnear C.J., Hemmings S.M., Seller C., Niehaus D.J., Knowles J.A., Daniels W., Moolman-Smook J.C., Seedat S., and Stein D.J. Hoarding in obsessive-compulsive disorder: clinical and genetic correlates. Journal of Clinical Psychiatry 66 9 (2005) 1155-1160
63. Lougee L., Perlmutter S.J., Nicolson R., Garvey M.A., and Swedo S.E. Psychiatric disorders in first-degree relatives of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS). Journal of the American Academy of Child and Adolescent Psychiatry 39 9 (2000) 1120-1126
64. Mataix D., Pertusa A., and Leckman J.F. Issues for DSM-V: how should obsessive-compulsive and related disorders be classified?. American Journal of Psychiatry, 164 9 (2007) 1313-1314
65. Mataix-Cols D., Wooderson S., Lawrence N., Brammer M.J., Speckens A., and Phillips M.L. Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive-compulsive disorder. Archives of General Psychiatry 61 6 (2004) 564-576
66. Meira-Lima I., Shavitt R.G., Miguita K., Ikenaga E., Miguel E.C., and Vallada H. Association analysis of the catechol-O-methyltransferase (COMT), serotonin transporter (5-HTT) and serotonin 2A receptor (5HT2A) gene polymorphisms with obsessive-compulsive disorder. Genes Brain and Behavior 3 2 (2004) 75-79
67. Menzies L., Achard S., Chamberlain S.R., Fineberg N., Chen C.H., Del Campo N., Sahakian B.J., Robbins T.W., and Bullmore E. Neurocognitive endophenotypes of obsessive-compulsive disorder. Brain 130 Pt 12 (2007) 3223-3236
68. Miguel E.C., Leckman J.F., Rauch S., do Rosario-Campos M.C., Hounie A.G., Mercadante M.T., Chacon P., and Pauls D.L. Obsessive-compulsive disorder phenotypes: implications for genetic studies. Molecular Psychiatry 10 3 (2005) 258-275
69. Millet B., Chabane N., Delorme R., Leboyer M., Leroy S., Poirier M.F., Bourdel M.C., Mouren-Simeoni M.C., Rouillon F., Loo H., and Krebs M.O. Association between the dopamine receptor D4 (DRD4) gene and obsessive-compulsive disorder. American Journal of Medical Genetics 116 1 Suppl (2003) 55-59
70. Mossner R., Daniel S., Albert D., Heils A., Okladnova O., Schmitt A., and Lesch K.P. Serotonin transporter function is modulated by brain-derived neurotrophic factor (BDNF) but not nerve growth factor (NGF). Neurochemestry International 36 3 (2000) 197-202
71. Mundo E., Richter M.A., Sam F., Macciardi F., and Kennedy J.L. Is the 5-HT(1Dbeta) receptor gene implicated in the pathogenesis of obsessive-compulsive disorder?. American Journal of Psychiatry 157 7 (2000) 1160-1161
72. Mundo E., Richter M.A., Zai G., Sam F., McBride J., Macciardi F., and Kennedy J.L. 5HT1dbeta receptor gene implicated in the pathogenesis of obsessive-compulsive disorder: further evidence from a family-based association study. Molecular Psychiatry 7 7 (2002) 805-809
73. Nestadt G., Lan T., Samuels J., Riddle M., Bienvenu III O.J., Liang K.Y., Hoehn-Saric R., Cullen B., Grados M., Beaty T.H., and Shugart Y.Y. Complex segregation analysis provides compelling evidence for a major gene underlying obsessive-compulsive disorder and for heterogeneity by sex. American Journal of Human Genetics 67 6 (2000) 1611-1616
74. Nestadt G., Samuels J., Riddle M., Bienvenu III O.J., Liang K.Y., LaBuda M., Walkup J., Grados M., and Hoehn-Saric R. A family study of obsessive-compulsive disorder. Archives of General Psychiatry 57 4 (2000) 358-363
75. Nicolini H., Hanna G., Baxter L., Schwartz J., Weissbacker K., and Spence M. Segregation analysis of obsessive compulsive and associated disorders. Ursus Medicus Journal 1 (1991) 25-28
76. Nicolini H., Cruz-Fuentes C., Camarena B., Orozco B., Kennedy J.L., King N., Weissbecker K., de la Fuente J.R., and Sidenberg D. DRD2, DRD3 and 5HT2A receptor genes polymorphisms in obsessive-compulsive disorder. Molecular Psychiatry 1 6 (1996) 461-465
77. Nicolini H., Cruz-Fuentes C., Camarena B., Paez F., and De la Fuente J.R. Understanding the genetic basis of obsessive-compulsive disorder. CNS Spectrums 4 5 (1999) 32-48
78. Nicolini H., Urraca N., Camarena B., Gomez A., Martinez H., Rinetti G., Campillo C., Castelli P., Apiquian R., Fresan A., Garcia-Anaya M., and Cruz-Fuentes C. Lack of association of apolipoprotein E polymorphism in obsessive-compulsive disorder. CNS Spectrums 6 12 (2001) 978-979 992
79. Niehaus D.J., Kinnear C.J., Corfield V.A., du Toit P.L., van Kradenburg J., Moolman-Smook J.C., Weyers J.B., Potgieter A., Seedat S., Emsley R.A., Knowles J.A., Brink P.A., and Stein D.J. Association between a catechol-O-methyltransferase polymorphism and obsessive-compulsive disorder in the Afrikaner population. Journal of Affective Disorders 65 1 (2001) 61-65
80. Pauls D.L. The genetics of obsessive compulsive disorder: a review of the evidence. American Journal of Medical Genetics 148 2 (2008) 133-139
81. Pauls D.L., Pakstis A.J., Kurlan R., Kidd K.K., Leckman J.F., Cohen D.J., Kidd J.R., Como P., and Sparkes R. Segregation and linkage analyses of Tourette's syndrome and related disorders. Journal of the American Academy of Child and Adolescent Psychiatry 29 2 (1990) 195-203
82. Pauls D.L., Alsobrook II J.P., Goodman W., Rasmussen S., and Leckman J.F. A family study of obsessive-compulsive disorder. American Journal of Psychiatry 152 1 (1995) 76-84
83. Pauls D.L., Alsobrook II J.P., Goodman W., Rasmussen S., and Leckman J.F. A family study of obsessive-compulsive disorder. American Journal of Psychiatry 152 1 (1999) 76-84
84. Penades R., Catalan R., Andres S., Salamero M., and Gasto C. Executive function and nonverbal memory in obsessive-compulsive disorder. Psychiatric Research 133 1 (2005) 81-90
85. Phillips K.A., Menard W., Fay C., and Weisberg R. Demographic characteristics, phenomenology, comorbidity, and family history in 200 individuals with body dysmorphic disorder. Psychosomatics 46 4 (2005) 317-325
86. Pinto A., Greenberg B.D., Grados M.A., Bienvenu III O.J., Samuels J.F., Murphy D.L., Hasler G., Stout R.L., Rauch S.L., Shugart Y.Y., Pauls D.L., Knowles J.A., Fyer A.J., McCracken J.T., Piacentini J., Wang Y., Willour V.L., Cullen B., Liang K.Y., Hoehn-Saric R., Riddle M.A., Rasmussen S.A., and Nestadt G. Further development of YBOCS dimensions in the OCD Collaborative Genetics Study: symptoms vs. categories. Psychiatry Research. 160 1 (2008) 83-93
87. Poyurovsky M., Michaelovsky E., Frisch A., Knoll G., Amir I., Finkel B., Buniak F., Hermesh H., and Weizman R. COMT Val158Met polymorphism in schizophrenia with obsessive-compulsive disorder: a case-control study. Neuroscience Letters 389 1 (2005) 21-24
88. Rosario-Campos M.C., Miguel E.C., Quatrano S., Chacon P., Ferrao Y., Findley D., Katsovich L., Scahill L., King R.A., Woody S.R., Tolin D., Hollander E., Kano Y., and Leckman J.F. The Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS): an instrument for assessing obsessive-compulsive symptom dimensions. Molecular Psychiatry 11 5 (2006) 495-504
89. Salema M., Sampaio A., Hounie A., Akkerman F., Curi M., Lopes A., and Miguel E.C. Prenatal, perinatal and postnatal risk factors for obsessive compulsive disorder. Biological Psychiatry 601 (2007) 301-307
90. Samuels J., Nestadt G., Bienvenu O.J., Costa Jr. P.T., Riddle M.A., Liang K.Y., Hoehn-Saric R., Grados M.A., and Cullen B.A. Personality disorders and normal personality dimensions in obsessive-compulsive disorder. British Journal of Psychiatry 177 (2000) 457-462
91. Samuels J., Shugart Y.Y., Grados M.A., Willour V.L., Bienvenu O.J., Greenberg B.D., Knowles J.A., McCracken J.T., Rauch S.L., Murphy D.L., Wang Y., Pinto A., Fyer A.J., Piacentini J., Pauls D.L., Cullen B., Rasmussen S.A., Hoehn-Saric R., Valle D., Liang K.Y., Riddle M.A., and Nestadt G. Significant linkage to compulsive hoarding on chromosome 14 in families with obsessive-compulsive disorder: results from the OCD Collaborative Genetics Study. American Journal of Psychiatry 164 3 (2007) 493-499
92. Santangelo S.L., Pauls D.L., Lavori P.W., Goldstein J.M., Faraone S.V., and Tsuang M.T. Assessing risk for the Tourette spectrum of disorders among first-degree relatives of probands with Tourette syndrome. American Journal of Medical Genetics 67 1 (1996) 107-116
93. Saxena S., Brody A.L., Maidment K.M., Smith E.C., Zohrabi N., Katz E., Baker S.K., and Baxter Jr. L.R. Cerebral glucose metabolism in obsessive-compulsive hoarding. American Journal of Psychiatry. 161 6 (2004) 1038-1048
94. Shetti C.N., Reddy Y.C., Kandavel T., Kashyap K., Singisetti S., Hiremath A.S., Siddequehusen M.U., and Raghunandanan S. Clinical predictors of drug nonresponse in obsessive-compulsive disorder. Journal of Clinical Psychiatry 66 12 (2005) 1517-1523 Dec
95. Shugart Y.Y., Samuels J., Willour V.L., Grados M.A., Greenberg B.D., Knowles J.A., McCracken J.T., Rauch S.L., Murphy D.L., Wang Y., Pinto A., Fyer A.J., Piacentini J., Pauls D.L., Cullen B., Page J., Rasmussen S.A., Bienvenu O.J., Hoehn-Saric R., Valle D., Liang K.Y., Riddle M.A., and Nestadt G. Genomewide linkage scan for obsessive-compulsive disorder: evidence for susceptibility loci on chromosomes 3q, 7p, 1q, 15q, and 6q. Molecular Psychiatry 11 8 (2006) 763-770
96. Stewart S.E., Platko J., Fagerness J., Birns J., Jenike E., Smoller J.W., Perlis R., Leboyer M., Delorme R., Chabane N., Rauch S.L., Jenike M.A., and Pauls D.L. A genetic family-based association study of OLIG2 in obsessive-compulsive disorder. Archives of General Psychiatry 64 2 (2007) 209-214
97. Stewart S.E., Rosario M.C., Brown T.A., Carter A.S., Leckman J.F., Sukhodolsky D., Katsovitch L., King R., Geller D., and Pauls D.L. Principal components analysis of obsessive-compulsive disorder symptoms in children and adolescents. Biological Psychiatry 61 3 (2007) 285-291
98. Stewart, S.E., Fagerness, J.A., Platko, J., Smoller, J.W., Scharf, J.M., Illmann, C., Jenike, E., Chabane, N., Leboyer, M., Delorme, R., Jenike, M.A., Pauls, D.L., 2007c. Association of the SLC1A1 Glutamate Transporter Gene and Obsessive-Compulsive Disorder. American Journal of Medial Genetics Part B: Neuropsychiatric Genetics 144 (8), 1027-1033.
99. Urraca N., Camarena B., Gomez-Caudillo L., Esmer M.C., and Nicolini H. Mu opioid receptor gene as a candidate for the study of obsessive compulsive disorder with and without tics. American Journal of Medical Genetics 127 B 1 (2004) 94-96
100. Van Grootheest D.S., Cath D.C., Beekman A.T., and Boomsma D.I. Twin studies on obsessive-compulsive disorder: a review. Twin Research Human Genetics 8 5 (2005) 450-458
101. Walitza S., Wewetzer C., Warnke A., Gerlach M., Geller F., Gerber G., Gorg T., Herpertz-Dahlmann B., Schulz E., Remschmidt H., Hebebrand J., and Hinney A. 5-HT2A promoter polymorphism-1438G/A in children and adolescents with obsessive-compulsive disorders. Molecular Psychiatry 7 10 (2002) 1054-1057
102. Walitza S., Wewetzer C., Gerlach M., Klampfl K., Geller F., Barth N., Hahn F., Herpertz-Dahlmann B., Gossler M., Fleischhaker C., Schulz E., Hebebrand J., Warnke A., and Hinney A. Transmission disequilibrium studies in children and adolescents with obsessive-compulsive disorders pertaining to polymorphisms of genes of the serotonergic pathway. Journal of Neural Transmission 111 7 (2004) 817-825
103. Wang Y., Samuels J.F., Chang Y.C., Grados M.A., Greenberg B.D., Knowles J.A., McCracken J.T., Rauch S.L., Murphy D.L., Rasmussen S.A., Cullen B., Hoehn-Saric R., Pinto A., Fyer A.J., Piacentini J., Pauls D.L., Bienvenu O.J., Riddle M., Shugart Y.Y., Liang K.Y., and Nestadt G. Gender differences in genetic linkage and association on 11p15 in obsessive-compulsive disorder families. American Journal of Medical Genetics B Neuropsychiatric Genetics 150B (2009) 30-40
104. Willour V.L., Yao Shugart Y., Samuels J., Grados M., Cullen B., Bienvenu III O.J., Wang Y., Liang K.Y., Valle D., Hoehn-Saric R., Riddle M., and Nestadt G. Replication study supports evidence for linkage to 9p24 in obsessive-compulsive disorder. American Journal of Human Genetics 75 3 (2004) 508-513
105. Zai G., Bezchlibnyk Y.B., Richter M.A., Arnold P.D., Burroughs E., Barr C.L., and Kennedy J.L. Myelin oligodendrocyte glycoprotein (MOG) gene is associated with obsessive-compulsive disorder. American Journal of Medical Genetics B (Neuropsychiatric Genetics) 129 1 (2004) 64-68
106. Zai G., Arnold P., Burroughs E., Barr C.L., Richter M.A., and Kennedy J.L. Evidence for the gamma-amino-butyric acid type B receptor 1 (GABBR1) gene as a susceptibility factor in obsessive-compulsive disorder. American Journal of Medical Genetics B (Neuropsychiatric Genetics) 134 1 (2005) 25-29
107. Zai G., Arnold P., Strauss J., King N., Burroughs E., Richter M.A., and Kennedy J.L. No association between brain-derived neurotrophic factor gene and obsessive-compulsive disorder. Psychiatric Genetics 15 4 (2005) 235
108. Zai G., Arnold P.D., Burroughs E., Richter M.A., and Kennedy J.L. Tumor necrosis factor-alpha gene is not associated with obsessive-compulsive disorder. Psychiatric Genetics 16 1 (2006) 43-45